AstraZeneca Pharmaceuticals, One Medimmune Way, Gaithersburg, MD, 20878, USA.
Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936, USA.
Ther Innov Regul Sci. 2020 Sep;54(5):1175-1184. doi: 10.1007/s43441-020-00142-2. Epub 2020 Mar 20.
There are limited quantitative approaches for evaluating rare safety outcomes from controlled clinical trials in either a blinded or unblinded setting. This manuscript demonstrates an application of three statistical methods for quantitative safety monitoring that can be implemented during any phase of a clinical trial, including open-label extension studies.
An interactive safety monitoring (iSM) tool was developed using R language in the publicly available R-Shiny app and was implemented for three statistical methods of quantitative safety monitoring. These methods are sequential probability ratio test (SPRT), maximized SPRT (MaxSPRT), and Bayesian posterior probability threshold (BPPT). The iSM tool evaluated specific safety signals that incorporated pre-specified background rates or reference risk ratios.
Two sets of blinded clinical trial data were used for case studies to demonstrate the use the iSM tool. Two particular adverse events, myocardial infarction (MI) and serious infection, were monitored. Monte Carlo simulation was conducted to evaluate the operating characteristics of pre-specified parameters. It showed that after adjusting for exposure, the BPPT and MaxSPRT yielded similar results in identifying a pre-specified signals while the SPRT method failed to detect such signals.
Statistical methods shown for the case studies, as well as the application of the user-friendly iSM tool, greatly enhance the quantitative monitoring of safety events of interest in ongoing clinical trials The BPPT and MaxSPRT methods seem more sensitive in picking-up early signals than the SPRT method when the number of safety events is small.
在盲法或非盲法环境下,评估对照临床试验中罕见安全性结局的定量方法有限。本文展示了三种可在临床试验的任何阶段(包括开放标签扩展研究)实施的定量安全性监测统计方法的应用。
使用 R 语言在公共的 R-Shiny 应用程序中开发了一个交互式安全性监测 (iSM) 工具,并实施了三种定量安全性监测的统计方法,即序贯概率比检验 (SPRT)、最大化 SPRT (MaxSPRT) 和贝叶斯后验概率阈值 (BPPT)。iSM 工具评估了特定的安全性信号,这些信号纳入了预先指定的背景发生率或参考风险比。
两个盲法临床试验数据集用于案例研究,以演示 iSM 工具的使用。监测了两种特定的不良事件,即心肌梗死 (MI) 和严重感染。进行了蒙特卡罗模拟来评估预定义参数的操作特征。结果表明,在调整了暴露因素后,BPPT 和 MaxSPRT 在识别预定义信号方面产生了相似的结果,而 SPRT 方法未能检测到此类信号。
案例研究中展示的统计方法以及用户友好的 iSM 工具的应用极大地增强了正在进行的临床试验中感兴趣的安全性事件的定量监测。当安全性事件数量较少时,BPPT 和 MaxSPRT 方法在发现早期信号方面似乎比 SPRT 方法更敏感。